BioSpace News Archive

ILC Dover LP, specializing in innovative single-use and chemical workflow solutions for biotherapeutics and pharmaceutical processing, announced plans to significantly expand production capabilities in its Juarez, Mexico facility.

Eisai Co., Ltd. announced the company will present research from its robust Alzheimer’s disease pipeline, including the latest findings on lecanemab, Eisai’s investigational anti-amyloid beta protofibril antibody for the treatment of early AD, at the AD/PD™ 2022 International Conference on Alzheimer’s and Parkinson’s Diseases from March 15-20 in Barcelona, Spain and virtually.

Royal Philips’ subsidiary, Philips Respironics, provided an update on the remediation status in the US of the ongoing recall of certain sleep and respiratory care products in connection with identified potential health risks related to the polyester-based polyurethane sound abatement foam in these devices.

The U.S. Food and Drug Administration issued a notification order to Philips Respironics requiring the company to notify patients and others of the company’s June 14, 2021, recall of certain Philips Respironics ventilators, continuous positive airway pressure and bilevel positive airway pressure machines, and the unreasonable risk of substantial harm to the public health posed by the degradation of the polyester-based polyurethane sound abatement foam used in those products.

Inari Medical, Inc., a medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced the pricing of an underwritten public offering of 2,000,000 shares of its common stock at a public offering price of $81.00 per share, before underwriting discounts and commissions.

Freeline Therapeutics Holdings plc announced that it has entered into a definitive agreement with Freeline’s majority shareholder, Syncona Portfolio Limited, a subsidiary of Syncona Limited, and certain other existing shareholders to purchase an aggregate of $26.1 million of its American Depositary Shares, each representing one ordinary share of the Company, at a price of $1.05 per ADS, in a registered direct offering.

Mirum Pharmaceuticals, Inc. announced that on March 10, 2022, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 16,350 shares of common stock and 8,150 restricted stock units to two new employees under Mirum’s 2020 Inducement Plan.

Videonystagmoscope is used to do Videonystagmography. VNG is a technology used for testing ear function and motor functions.

Albany NY, United States: The urolithiasis management devices market has a highly competitive vendor landscape, observes Transparency Market Research.

DUBAI, United Arab Emirates, Global sales of upper limb prosthetics stood at around US$ 379 Mn in 2022.